Profile data is unavailable for this security.
About the company
BioNeutra Global Corporation, through its subsidiaries, is involved in the research, development, production and commercialization of ingredients for nutraceutical, functional and mainstream foods and beverages, with a focus on oligosaccharides. The Company’s lead product, VitaFiber IMO, is an advanced functional and health food ingredient naturally derived from agricultural products. VitaFiber IMO is naturally sweet and lower in calories than sugar and is a natural source of dietary fiber as it provides low calorie soluble prebiotic fiber for human digestive health. It produces VitaFiber IMO using its patented production processes that naturally transform starch molecules from agriculture cereal crops, including tapioca, field pea or corn into the functional health molecules of isomalto-oligosaccharide. VitaFiber IMO is also available for retail purchase across the globe through Amazon.com and Shopify.com. The Company’s customers include a mix of small and medium enterprises.
- Revenue in CAD (TTM)10.34m
- Net income in CAD-1.53m
- Incorporated1996
- Employees--
- LocationBioNeutra Global Corp9608 - 25 Avenue NWEDMONTON T6N 1J4CanadaCAN
- Phone+1 (780) 466-1481
- Fax+1 (780) 466-1481
- Websitehttps://www.bioneutra.ca/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NeutriSci International Inc | 59.98k | -552.46k | 892.12k | -- | -- | -- | -- | 14.87 | -0.0032 | -0.0032 | 0.0003 | -0.0051 | 0.2988 | 1.33 | 11.47 | -- | -275.23 | -288.65 | -- | -- | -43.90 | -7.95 | -921.07 | -1,046.33 | 0.0059 | -- | -- | -- | 465.89 | 24.82 | 50.98 | -- | -- | -- |
| BioNeutra Global Corp | 10.34m | -1.53m | 1.39m | -- | -- | -- | -- | 0.1347 | -0.0329 | -0.0329 | 0.2224 | -0.168 | 0.6866 | 1.50 | 10.03 | -- | -10.18 | -18.99 | -- | -59.57 | 45.48 | 13.69 | -14.83 | -23.54 | 0.1267 | -1.48 | -- | -- | -15.00 | -21.31 | 27.86 | -- | -52.78 | -- |
| GLG Life Tech Corp | 13.90m | -11.97m | 1.92m | 12.00 | -- | -- | -- | 0.1381 | -0.3117 | -0.2518 | 0.362 | -4.76 | 0.9111 | 4.60 | 6.03 | 1,158,393.00 | -78.28 | -31.27 | -- | -- | 32.32 | 30.57 | -85.92 | -74.99 | 0.0416 | 0.2637 | -- | -- | -1.45 | -9.05 | -49.84 | -- | -69.09 | -- |
